[Cardiac magnetic resonance and uremic cardiomyopathy]. / Storia naturale della cardiomiopatia uremica analizzata con gli "occhi" della risonanza magnetica nucleare.
G Ital Nefrol
; 31(6)2014.
Article
en It
| MEDLINE
| ID: mdl-25504164
ABSTRACT
Cardiovascular disease (CV) represents the main risk factor for morbidity and mortality in chronic kidney disease (CKD) patients. Large epidemiological studies have shown direct association between severity of CKD and CV event rates. Although patients with end-stage renal disease (ESRD), including dialysis ones, are at greater CV risk, cardiovascular involvement is already evident at the early stages of CKD. End-stage CKD is characterized conventional atherosclerotic risk factor but they cannot account for CV risk as reï¬ected in high rates of sudden cardiac death, heart failure and myocardial infarction. Non-atherosclerotic processes, including left ventricular hypertrophy and ï¬brosis, mostly account for the excess risk of CV. Employment of cardiac magnetic resonance (CMR) in CKD has brought an improved understanding of the adverse CV changes, known as uremic cardiomyopathy. It is due to ability of cardiac magnetic resonance to provide a comprehensive non - invasive examination of cardiac structure and function, arterial function, myocardial tissue characterization (T1 mapping and inversion recovery imaging), and myocardial metabolic function (spectroscopy).
Buscar en Google
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Uremia
/
Espectroscopía de Resonancia Magnética
/
Insuficiencia Renal Crónica
/
Técnicas de Imagen Cardíaca
/
Cardiomiopatías
Tipo de estudio:
Etiology_studies
/
Risk_factors_studies
Límite:
Humans
Idioma:
It
Revista:
G Ital Nefrol
Asunto de la revista:
NEFROLOGIA
Año:
2014
Tipo del documento:
Article